bovine somatotropin

(redirected from Recombinant bovine somatotropin)
Also found in: Dictionary, Acronyms.

bovine somatotropin

A 190-amino acid protein produced by the bovine pituitary, which evokes somatic growth (partially mediated by insulin-like growth factor) and increased milk production.
References in periodicals archive ?
Effect of recombinant bovine somatotropin on growth performance and puberty incidence of male and female lambs born from rbST treated ewes.
Doseresponse effects of recombinant bovine somatotropin (Posilac) on growth performance and body composition of two-year-old rainbow trout (Oncorhynchus mykiss).
Administration of recombinant bovine somatotropin to dairy cows in four consecutive lactations, J.
Effects of supplemental recombinant bovine somatotropin (rbST) and cooling with misters and fans on renal function in relation to regulation of body fluids in different stages of lactation in crossbred Holstein cattle.
Effect of long-term treatment with recombinant bovine somatotropin and estradiol on hormone concentrations and ovulatory response of superovulated cattle.
In related news, several states are considering legislation that would regulate label claims for milk from farms that agree not to use the recombinant bovine somatotropin (rBST) production stimulant, the International Dairy Foods Association (IDFA) said on February 19.
John Fetrow (Economics of Recombinant Bovine Somatotropin, 1999) has estimated that in adequately managed dairy herds, farmers can earn at least a 50-percent profit over the expenses of using the product, given typical prices for milk and feed.
Some of these products are treated with recombinant bovine somatotropin (rbST) and some are not.
5 million hectares, and dairy farm demand for recombinant bovine somatotropin will continue to grow, but at a lesser extent than in previous years.
Dairy farm demand for recombinant bovine somatotropin will continue to grow, although to a lesser extent than in previous years, given a weak dairy market and ongoing culling of dairy farmer ranks.
The Regulation would have included the biotech-derived recombinant bovine somatotropin (rBST) hormone used for therapeutic purposes in Annex II of Regulation 2377/90/EEC laying down the Community procedure for setting such threshold levels.
In November 1993, the FDA approved the sale of milk from cows treated with recombinant bovine somatotropin (rBST), a genetically engineered version of a naturally occurring growth hormone.

Full browser ?